ERAP基因间区rs75862629次要等位基因影响HLA-B27表达并预防撒丁岛强直性脊柱炎
在撒丁岛人群中,ERAP2启动子区SNP rs75862629的次要等位基因G在HLA-B27阳性健康个体(含B*2705和B*2709)中显著高于B*2705阳性AS患者和B27阴性对照。该SNP通过影响转录因子结合,同时调节ERAP1和ERAP2表达,并改变HLA-B*2705与B*2709的细胞表面表达,从而提供对AS的保护。
要点
- rs75862629次要等位基因G在HLA-B27阳性健康人中显著增加,与AS保护相关。
- 该SNP影响转录因子结合,导致ERAP2表达降低而ERAP1表达升高。
- 该SNP与HLA-B*2705和B*2709的细胞表面表达差异相关。
核心结论
- rs75862629通过同时调节ERAP1和ERAP2表达,在撒丁岛HLA-B27阳性个体中提供对AS的保护,并影响HLA-B27表达及可能影响疾病发生。
研究设计与样本
- 对145例HLA-B*2705阳性AS患者、126例B27阳性健康者和250例B27阴性对照的ERAP区4个SNP进行基因分型并推导等位基因和单倍型频率。
- 在36株HLA-B27阳性B淋巴母细胞系中用定量PCR检测ERAP1和ERAP2 mRNA表达,用凝胶迁移实验寻找结合rs75862629序列的核因子,用流式细胞术检测HLA-B27分子表达。
主要发现
- rs75862629的次要等位基因G在B27健康个体(B*2705和B*2709)中较B*2705阳性AS患者和B27阴性对照显著增加。
- 凝胶迁移实验提示转录因子结合缺失是ERAP2表达降低伴ERAP1表达升高的原因。
- 该SNP伴随HLA-B*2705和HLA-B*2709分子细胞表面表达的不同。
临床怎么用
- 在撒丁岛HLA-B27阳性人群中,rs75862629次要等位基因G可能作为AS保护性标志物。
- 该SNP对ERAP1/ERAP2表达的同步调节及HLA-B27表达的影响,提示其可能参与AS发病机制。
局限性
- 研究限于撒丁岛人群,结论外推需谨慎。
- 功能实验基于B淋巴母细胞系,体内验证不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: HLA-B27 and the endoplasmic reticulum aminopeptidase 1 (ERAP1) and ERAP2 genes are predisposing factors for AS. A single nucleotide polymorphism (SNP) in the ERAP2 promoter (rs75862629) coordinates the transcription of both ERAP genes. We investigated whether this SNP associates with AS and whether it affects the expression of the two major HLA-B27 alleles present in Sardinia, the AS-associated B*2705 and the non-AS-associated B*2709. METHODS: Four SNPs in the ERAP region were genotyped in HLA-B*2705-positive patients with AS (n = 145), B27-positive healthy subjects (n = 126) and B27-negative controls (n = 250) and the allele and haplotype frequencies were derived. The expression of ERAP1 and ERAP2 mRNAs in 36 HLA-B27-positive B lymphoblastoid cell lines was measured by quantitative PCR. An electrophoretic mobility shift assay was performed to search for a nuclear factor binding the DNA sequence encompassing rs75862629. The expression of HLA-B27 molecules related to the SNP at rs75862629 was determined by flow cytometry. RESULTS: The minor allele G at rs75862629 was found significantly increased in B27 healthy individuals, both B*2705 and B*2709, compared with B*2705-positive patients with AS and B27-negative controls. The electrophoretic mobility shift assay indicated the lack of binding of a transcription factor as the cause of the observed reduction in the ERAP2 concomitant with a higher ERAP1 expression. Of note, this occurs with a different cell surface expression of the HLA-B*2705 and HLA-B*2709 molecules. CONCLUSION: SNP rs75862629, by modulating simultaneously the expression of ERAP1 and ERAP2, provides protection from AS in HLA-B27-positive subjects in Sardinia. This has a functional impact on HLA-B27 expression and likely on disease onset.
引用
- Paladini F, Fiorillo MT, Tedeschi V, et al. The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia. Rheumatology (Oxford). 2019. PMID: 31209470. doi:10.1093/rheumatology/kez212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。